Related Experiment Video
Updated: May 25, 2026

Transmitochondrial Cybrid Generation Using Cancer Cell Lines
Published on: March 17, 2023
Consumption of oxygen: a mitochondrial-generated progression signal of advanced cancer
1Department of Biochemistry and Molecular Biology, University of Arkansas for Medical Sciences, Little Rock, AR 72205, USA.
Abstract:
Changes in mitochondrial genome such as mutation, deletion and depletion are common in cancer and can determine advanced phenotype of cancer; however, detailed mechanisms have not been elucidated. We observed that loss of mitochondrial genome reversibly induced overexpression and activation of proto-oncogenic Ras, especially K-Ras 4A, responsible for the activation of AKT and ERK leading to advanced phenotype of prostate and breast cancer. Ras activation was induced by the overexpression of 3-hydroxy-3-methyl-glutaryl-CoA reductase (HMGR), the rate-limiting enzyme of the mevalonate pathway. Hypoxia is known to induce proteasomal degradation of HMGR. Well differentiated prostate and breast cancer cells with high mitochondrial DNA content consumed a large amount of oxygen and induced hypoxia. Loss of mitochondrial genome reduced oxygen consumption and increased in oxygen concentration in the cells. The hypoxic-to-normoxic shift led to the overexpression of HMGR through inhibiting proteasomal degradation. Therefore, reduction of mitochondrial genome content induced overexpression of HMGR through hypoxic to normoxic shift and subsequently the endogenous induction of the mevalonate pathway activated Ras that mediates advanced phenotype. Reduction of mitochondrial genome content was associated with the aggressive phenotype of prostate cancer in vitro cell line model and tissue specimens in vivo. Our results elucidate a coherent mechanism that directly links the mitochondrial genome with the advanced progression of the disease.
Insights
Loss of mitochondrial genome in cancer cells triggers Ras activation, promoting aggressive tumor growth. This occurs via a pathway involving HMGR overexpression and altered oxygen levels, linking mitochondrial health to cancer progression.
Area of Science:
- Biochemistry
- Molecular Biology
- Cancer Research
Background:
- Mitochondrial genome alterations are common in cancer, but mechanisms driving advanced phenotypes remain unclear.
- Proto-oncogenic Ras proteins play a critical role in cancer cell signaling and proliferation.
- The mevalonate pathway, regulated by HMGR, is crucial for cellular biosynthesis and signaling.
Purpose of the Study:
- To elucidate the mechanism linking mitochondrial genome loss to cancer progression.
- To investigate the role of Ras activation in mitochondrial genome-associated cancer phenotypes.
- To explore the involvement of the mevalonate pathway and hypoxia in this process.
Main Methods:
- Investigated changes in mitochondrial genome content in cancer cells.
- Assessed the expression and activation of Ras, AKT, and ERK signaling pathways.
- Measured oxygen consumption and cellular oxygen concentration.
- Analyzed the expression of 3-hydroxy-3-methyl-glutaryl-CoA reductase (HMGR) under varying oxygen conditions.
- Utilized in vitro cell line models and in vivo tissue specimens of prostate and breast cancer.
Main Results:
- Loss of mitochondrial genome led to reversible overexpression and activation of Ras, particularly K-Ras 4A.
- Ras activation was mediated by HMGR overexpression, induced by a hypoxic-to-normoxic shift.
- Reduced mitochondrial genome content decreased oxygen consumption, creating a normoxic environment that upregulated HMGR.
- This pathway was linked to advanced phenotypes in prostate and breast cancer cells and tissues.
Conclusions:
- Mitochondrial genome reduction promotes cancer progression by inducing HMGR overexpression and Ras activation via oxygen level changes.
- This study reveals a novel mechanism connecting mitochondrial integrity to aggressive cancer phenotypes.
- Targeting this pathway could offer new therapeutic strategies for advanced prostate and breast cancers.
Related Concept Videos
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Electron Transport Chain: Complex I and II
ROS generation is regulated and maintained at moderate levels necessary...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Mitochondrial Membranes
